(Z)-2-Acetyl-4-(4-chlorophenyl)-6-(thiophen-2-ylmethylidene)-4H-1,3,4-thiadiazin-5(6H)-one (6g).
Yield 2.4 g (66%). Yellow crystals; mp 187-188°C. IR spectrum, ν, cm-1: 1678, 1684 (CO). 1H NMR spectrum,
13
δ, ppm: 2.66 (3H, s, CH3); 7.54-8.00 (7H, m, H Ar); 8.11 (1H, s, ArCH). C NMR spectrum, δ, ppm: 193.1
(C=O); 160.3 (C=O); 147.0 (C=N); 142.6; 139.5; 135.6; 133.8; 129.4; 128.6; 128.0; 126.7; 116.3 (C Ar); 110.6
(ArCH); 26.8 (CH3). Found, %: C 53.17; H 3.24; N 7.96; S 17.85. C16H11ClN2O2S2. Calculated, %: C 52.96;
H 3.06; N 7.72; S 17.67.
(Z)-2-Acetyl-4-(4-chlorophenyl)-6-(furan-2-ylmethylidene)-4H-1,3,4-thiadiazin-5(6H)-one
(6h).
Yield 2.1 g (61%). Yellow crystals; mp 196-197°C. IR spectrum, ν, cm-1: 1672, 1680 (CO). 1H NMR spectrum,
δ, ppm: 2.60 (3H, s, CH3); 7.68-8.00 (7H, m, H Ar); 8.07 (1H, s, ArCH). Found, %: C 55.20; H 3.39; N 8.32; S
9.07. C16H11ClN2O3S. Calculated, %: C 55.42; H 3.20; N 8.08; S 9.25.
X-Ray Structure Investigation of Compound 6b. The X-ray diffraction measurements were carried out
at wavelength 0.71073 Å. Crystal parameters for compound 6b: C16H12N2O2S2; M 328.40; crystal system
orthorhombic, space group Pbca. Unit cell dimensions: a 12.158(2), b 7.391(2), c 33.885(7) Å; α 90, β 90,
γ 90°; V 3044.9(12) Å3; T -75(2)°C; Z 8; dcalc 1.433 g/cm3; μ 0.357 cm-1. Total 45297 reflections are measured,
[sin(θ)/λ]max 0.64°·Å-1 / 99.8%; wR2 factor 0.100; ρ 0.53 (-0.37) e·Å-3. Crystallographic data of compound 6b
have been deposited at the Cambridge Crystallographic Data Center (deposit CCDC 746860).
REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
D. Villemin and A. B. Alloum, Phosphorus, Sulfur Silicon Relat. Elem., 79, 33 (1993).
K. H. Patel and A. G. Mehta, E-J. Chem., 3, 103 (2006).
S. Kambe, K. Saito, A. Sakurai, and H. Midorikawa, Synthesis, 531 (1981).
S. O. Abd Allah, H. A. Hammouda, and F. A. Ali, J. Heterocycl. Chem., 22, 497 (1985).
D. N. Kachru, S. Singh, and S. K. Tandon, Toxicol. Lett., 57, 251 (1991).
S. K. Tandon, S. Prasad, and S. Singh, Biomed. Environ. Sci., 3, 205(2000).
M. Chatterjee, V. K. Dwivedi, K. Khandekar, and S. K. Tandon, Biomed. Environ. Sci., 17, 27 (2004).
A. K. Shakya, P. Mishra, G. K. Patnaik, R. Shukla, and R. C. Srimal, Arch. Pharm. Res., 21, 753
(1998).
9.
10.
M. J. Pawar, A. B. Burungale, and B. K. Karale, ARKIVOC, xiii, 97 (2009).
J. Schroder, A. Henke, H. Wenzel, H. Brandstetter, H. G. Stammler, A. Stammler, W. D. Pfeiffer, and
H. Tschesche, J. Med. Chem., 44, 3231 (2001).
11.
12.
13.
14.
H. Tschesche and J. Schroder, EP Pat. Appl. 1191024.
H. Sugawara and M. Endoh, Jpn. J. Pharmacol., 80, 55 (1999).
H. M. Himmel, G. J. Amos, E. Wettwer, and U. Ravens, J. Cardiovasc. Pharmacol., 33, 301 (1999).
H. N. Dogan, A. Duran, S. Rollas, G. Sener, M. K Uysal, and D. Gulen, Bioorg. Med. Chem., 10, 2893
(2002).
15.
16.
S. A. Carvalho, E. F. Da-Silva, R. M. Santa-Rita, S. L. De-Castro, and C. A. M. Fraga, Bioorg. Med.
Chem. Lett., 14, 5967 (2004).
S. N. Swamy, Basappa, B. S. Priya, B. Prabhuswamy, B. H. Doreswamy, J. S. Prasad, and
K. S. Rangappa, Eur. J. Med. Chem., 41, 531 (2006).
17.
18.
19.
20.
21.
22.
23.
S. O. Abd Allah, H. A. Ead, N. A. Kassab, and N. H. Metwali, Heterocycles, 20, 637 (1983).
S. O. Abdallah, H. A. Hammoude, and N. H. Metwally, Egypt. J. Chem., 28, 497 (1985).
H. A. Ead and N. H. Metwally, Arch. Pharm., 323, 57 (1990).
H. A. Ead, M. A. Abdelaziz, and N. H. Metwally, Pol. J. Chem., 65, 1291 (1991).
H. A. Ead, S. O. Abdallah, N. A. Kassab, and N. H. Metwally, Sulfur Lett., 9, 23 (1989).
H. A. Ead, N. H. Metwalli, and N. M. Morsi, Arch. Pharm. Res., 13, 5 (1990).
N. H. Metwally, Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem., 39B: 757 (2000).
1699